Cross-variant protection against SARS-CoV-2 infection in hamsters immunized with monovalent and bivalent inactivated vaccines

Rapid development and successful use of vaccines against SARS-CoV-2 might hold the key to curb the ongoing pandemic of COVID-19. Emergence of vaccine-evasive SARS-CoV-2 variants of concern (VOCs) has posed a new challenge to vaccine design and development. One urgent need is to determine what types...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Zi-Wei, Fan, Yilan, Tang, Kaiming, Ong, Chon Phin, Luo, Cuiting, Chung, Hon-Lam, Leong, Tsun-Lam, Liang, Ronghui, Lui, Wai-Yin, Zhou, Runhong, Cheng, Yun, Lu, Lu, Cheung, Pak-Hin Hinson, Chan, Jasper Fuk-Woo, Chen, Zhiwei, Yuen, Kwok-Yung, Yuan, Shuofeng, To, Kelvin Kai-Wang, Jin, Dong-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305277/
https://www.ncbi.nlm.nih.gov/pubmed/35874942
http://dx.doi.org/10.7150/ijbs.72109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305277/
https://www.ncbi.nlm.nih.gov/pubmed/35874942
http://dx.doi.org/10.7150/ijbs.72109

Ejemplares similares